Global Biological Pentylenediamine for Medicine Supply, Demand and Key Producers, 2023-2029
The global Biological Pentylenediamine for Medicine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Pentylenediamine, also known as 1,5-diaminopentane, is an important C5 platform compound. It is a colorless fuming liquid with an odor similar to ammonia gas and is easily soluble in water and ethanol. Kasai uses renewable plant resources as raw materials to produce high-purity biological pentylenediamine through specific biological transformation process.
Pentylenediamine can be used in polyamide, pentamethylene diisocyanate (PDI), epoxy resin curing agent, organic synthesis intermediates, etc., and can be further used in spinning, engineering materials, medicine, pesticides, organic synthesis and other fields.
This report studies the global Biological Pentylenediamine for Medicine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biological Pentylenediamine for Medicine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biological Pentylenediamine for Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biological Pentylenediamine for Medicine total production and demand, 2018-2029, (Tons)
Global Biological Pentylenediamine for Medicine total production value, 2018-2029, (USD Million)
Global Biological Pentylenediamine for Medicine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Biological Pentylenediamine for Medicine consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: Biological Pentylenediamine for Medicine domestic production, consumption, key domestic manufacturers and share
Global Biological Pentylenediamine for Medicine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global Biological Pentylenediamine for Medicine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Biological Pentylenediamine for Medicine production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons).
This reports profiles key players in the global Biological Pentylenediamine for Medicine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cathay Biotech, Aphena Pharma Solutions, Bio-Tech Pharmacal, Goodwin Biotechnology, Xenon Pharmaceuticals, Nektar Therapeutics, Midas Pharmaceuticals, Kedrion Biopharma and Xcelthera, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biological Pentylenediamine for Medicine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biological Pentylenediamine for Medicine Market, By Region:
1. How big is the global Biological Pentylenediamine for Medicine market?
2. What is the demand of the global Biological Pentylenediamine for Medicine market?
3. What is the year over year growth of the global Biological Pentylenediamine for Medicine market?
4. What is the production and production value of the global Biological Pentylenediamine for Medicine market?
5. Who are the key producers in the global Biological Pentylenediamine for Medicine market?
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Pentylenediamine, also known as 1,5-diaminopentane, is an important C5 platform compound. It is a colorless fuming liquid with an odor similar to ammonia gas and is easily soluble in water and ethanol. Kasai uses renewable plant resources as raw materials to produce high-purity biological pentylenediamine through specific biological transformation process.
Pentylenediamine can be used in polyamide, pentamethylene diisocyanate (PDI), epoxy resin curing agent, organic synthesis intermediates, etc., and can be further used in spinning, engineering materials, medicine, pesticides, organic synthesis and other fields.
This report studies the global Biological Pentylenediamine for Medicine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biological Pentylenediamine for Medicine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biological Pentylenediamine for Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biological Pentylenediamine for Medicine total production and demand, 2018-2029, (Tons)
Global Biological Pentylenediamine for Medicine total production value, 2018-2029, (USD Million)
Global Biological Pentylenediamine for Medicine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Biological Pentylenediamine for Medicine consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: Biological Pentylenediamine for Medicine domestic production, consumption, key domestic manufacturers and share
Global Biological Pentylenediamine for Medicine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global Biological Pentylenediamine for Medicine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Biological Pentylenediamine for Medicine production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons).
This reports profiles key players in the global Biological Pentylenediamine for Medicine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cathay Biotech, Aphena Pharma Solutions, Bio-Tech Pharmacal, Goodwin Biotechnology, Xenon Pharmaceuticals, Nektar Therapeutics, Midas Pharmaceuticals, Kedrion Biopharma and Xcelthera, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biological Pentylenediamine for Medicine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biological Pentylenediamine for Medicine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Purity 98.5%-99%
- Purity ?99%
- Pharmaceutical Industry
- Medical Research
- Others
- Cathay Biotech
- Aphena Pharma Solutions
- Bio-Tech Pharmacal
- Goodwin Biotechnology
- Xenon Pharmaceuticals
- Nektar Therapeutics
- Midas Pharmaceuticals
- Kedrion Biopharma
- Xcelthera
- Anichem
- ALC Bio Innovations
- ACADIA Pharmaceuticals
- AbbVie
- Ology Bioservices
- QMI - Quality Management
- Biomiga
- Molecular Targeting Technologies
1. How big is the global Biological Pentylenediamine for Medicine market?
2. What is the demand of the global Biological Pentylenediamine for Medicine market?
3. What is the year over year growth of the global Biological Pentylenediamine for Medicine market?
4. What is the production and production value of the global Biological Pentylenediamine for Medicine market?
5. Who are the key producers in the global Biological Pentylenediamine for Medicine market?
1 SUPPLY SUMMARY
1.1 Biological Pentylenediamine for Medicine Introduction
1.2 World Biological Pentylenediamine for Medicine Supply & Forecast
1.2.1 World Biological Pentylenediamine for Medicine Production Value (2018 & 2022 & 2029)
1.2.2 World Biological Pentylenediamine for Medicine Production (2018-2029)
1.2.3 World Biological Pentylenediamine for Medicine Pricing Trends (2018-2029)
1.3 World Biological Pentylenediamine for Medicine Production by Region (Based on Production Site)
1.3.1 World Biological Pentylenediamine for Medicine Production Value by Region (2018-2029)
1.3.2 World Biological Pentylenediamine for Medicine Production by Region (2018-2029)
1.3.3 World Biological Pentylenediamine for Medicine Average Price by Region (2018-2029)
1.3.4 North America Biological Pentylenediamine for Medicine Production (2018-2029)
1.3.5 Europe Biological Pentylenediamine for Medicine Production (2018-2029)
1.3.6 China Biological Pentylenediamine for Medicine Production (2018-2029)
1.3.7 Japan Biological Pentylenediamine for Medicine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biological Pentylenediamine for Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biological Pentylenediamine for Medicine Major Market Trends
2 DEMAND SUMMARY
2.1 World Biological Pentylenediamine for Medicine Demand (2018-2029)
2.2 World Biological Pentylenediamine for Medicine Consumption by Region
2.2.1 World Biological Pentylenediamine for Medicine Consumption by Region (2018-2023)
2.2.2 World Biological Pentylenediamine for Medicine Consumption Forecast by Region (2024-2029)
2.3 United States Biological Pentylenediamine for Medicine Consumption (2018-2029)
2.4 China Biological Pentylenediamine for Medicine Consumption (2018-2029)
2.5 Europe Biological Pentylenediamine for Medicine Consumption (2018-2029)
2.6 Japan Biological Pentylenediamine for Medicine Consumption (2018-2029)
2.7 South Korea Biological Pentylenediamine for Medicine Consumption (2018-2029)
2.8 ASEAN Biological Pentylenediamine for Medicine Consumption (2018-2029)
2.9 India Biological Pentylenediamine for Medicine Consumption (2018-2029)
3 WORLD BIOLOGICAL PENTYLENEDIAMINE FOR MEDICINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Biological Pentylenediamine for Medicine Production Value by Manufacturer (2018-2023)
3.2 World Biological Pentylenediamine for Medicine Production by Manufacturer (2018-2023)
3.3 World Biological Pentylenediamine for Medicine Average Price by Manufacturer (2018-2023)
3.4 Biological Pentylenediamine for Medicine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biological Pentylenediamine for Medicine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biological Pentylenediamine for Medicine in 2022
3.5.3 Global Concentration Ratios (CR8) for Biological Pentylenediamine for Medicine in 2022
3.6 Biological Pentylenediamine for Medicine Market: Overall Company Footprint Analysis
3.6.1 Biological Pentylenediamine for Medicine Market: Region Footprint
3.6.2 Biological Pentylenediamine for Medicine Market: Company Product Type Footprint
3.6.3 Biological Pentylenediamine for Medicine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Biological Pentylenediamine for Medicine Production Value Comparison
4.1.1 United States VS China: Biological Pentylenediamine for Medicine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Biological Pentylenediamine for Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Biological Pentylenediamine for Medicine Production Comparison
4.2.1 United States VS China: Biological Pentylenediamine for Medicine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biological Pentylenediamine for Medicine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Biological Pentylenediamine for Medicine Consumption Comparison
4.3.1 United States VS China: Biological Pentylenediamine for Medicine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Biological Pentylenediamine for Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Biological Pentylenediamine for Medicine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Biological Pentylenediamine for Medicine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Biological Pentylenediamine for Medicine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Biological Pentylenediamine for Medicine Production (2018-2023)
4.5 China Based Biological Pentylenediamine for Medicine Manufacturers and Market Share
4.5.1 China Based Biological Pentylenediamine for Medicine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Biological Pentylenediamine for Medicine Production Value (2018-2023)
4.5.3 China Based Manufacturers Biological Pentylenediamine for Medicine Production (2018-2023)
4.6 Rest of World Based Biological Pentylenediamine for Medicine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Biological Pentylenediamine for Medicine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Biological Pentylenediamine for Medicine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Biological Pentylenediamine for Medicine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biological Pentylenediamine for Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Purity 98.5%-99%
5.2.2 Purity ?99%
5.3 Market Segment by Type
5.3.1 World Biological Pentylenediamine for Medicine Production by Type (2018-2029)
5.3.2 World Biological Pentylenediamine for Medicine Production Value by Type (2018-2029)
5.3.3 World Biological Pentylenediamine for Medicine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biological Pentylenediamine for Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Industry
6.2.2 Medical Research
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Biological Pentylenediamine for Medicine Production by Application (2018-2029)
6.3.2 World Biological Pentylenediamine for Medicine Production Value by Application (2018-2029)
6.3.3 World Biological Pentylenediamine for Medicine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Cathay Biotech
7.1.1 Cathay Biotech Details
7.1.2 Cathay Biotech Major Business
7.1.3 Cathay Biotech Biological Pentylenediamine for Medicine Product and Services
7.1.4 Cathay Biotech Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Cathay Biotech Recent Developments/Updates
7.1.6 Cathay Biotech Competitive Strengths & Weaknesses
7.2 Aphena Pharma Solutions
7.2.1 Aphena Pharma Solutions Details
7.2.2 Aphena Pharma Solutions Major Business
7.2.3 Aphena Pharma Solutions Biological Pentylenediamine for Medicine Product and Services
7.2.4 Aphena Pharma Solutions Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Aphena Pharma Solutions Recent Developments/Updates
7.2.6 Aphena Pharma Solutions Competitive Strengths & Weaknesses
7.3 Bio-Tech Pharmacal
7.3.1 Bio-Tech Pharmacal Details
7.3.2 Bio-Tech Pharmacal Major Business
7.3.3 Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Product and Services
7.3.4 Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bio-Tech Pharmacal Recent Developments/Updates
7.3.6 Bio-Tech Pharmacal Competitive Strengths & Weaknesses
7.4 Goodwin Biotechnology
7.4.1 Goodwin Biotechnology Details
7.4.2 Goodwin Biotechnology Major Business
7.4.3 Goodwin Biotechnology Biological Pentylenediamine for Medicine Product and Services
7.4.4 Goodwin Biotechnology Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Goodwin Biotechnology Recent Developments/Updates
7.4.6 Goodwin Biotechnology Competitive Strengths & Weaknesses
7.5 Xenon Pharmaceuticals
7.5.1 Xenon Pharmaceuticals Details
7.5.2 Xenon Pharmaceuticals Major Business
7.5.3 Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Product and Services
7.5.4 Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Xenon Pharmaceuticals Recent Developments/Updates
7.5.6 Xenon Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Nektar Therapeutics
7.6.1 Nektar Therapeutics Details
7.6.2 Nektar Therapeutics Major Business
7.6.3 Nektar Therapeutics Biological Pentylenediamine for Medicine Product and Services
7.6.4 Nektar Therapeutics Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Nektar Therapeutics Recent Developments/Updates
7.6.6 Nektar Therapeutics Competitive Strengths & Weaknesses
7.7 Midas Pharmaceuticals
7.7.1 Midas Pharmaceuticals Details
7.7.2 Midas Pharmaceuticals Major Business
7.7.3 Midas Pharmaceuticals Biological Pentylenediamine for Medicine Product and Services
7.7.4 Midas Pharmaceuticals Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Midas Pharmaceuticals Recent Developments/Updates
7.7.6 Midas Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Kedrion Biopharma
7.8.1 Kedrion Biopharma Details
7.8.2 Kedrion Biopharma Major Business
7.8.3 Kedrion Biopharma Biological Pentylenediamine for Medicine Product and Services
7.8.4 Kedrion Biopharma Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Kedrion Biopharma Recent Developments/Updates
7.8.6 Kedrion Biopharma Competitive Strengths & Weaknesses
7.9 Xcelthera
7.9.1 Xcelthera Details
7.9.2 Xcelthera Major Business
7.9.3 Xcelthera Biological Pentylenediamine for Medicine Product and Services
7.9.4 Xcelthera Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Xcelthera Recent Developments/Updates
7.9.6 Xcelthera Competitive Strengths & Weaknesses
7.10 Anichem
7.10.1 Anichem Details
7.10.2 Anichem Major Business
7.10.3 Anichem Biological Pentylenediamine for Medicine Product and Services
7.10.4 Anichem Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Anichem Recent Developments/Updates
7.10.6 Anichem Competitive Strengths & Weaknesses
7.11 ALC Bio Innovations
7.11.1 ALC Bio Innovations Details
7.11.2 ALC Bio Innovations Major Business
7.11.3 ALC Bio Innovations Biological Pentylenediamine for Medicine Product and Services
7.11.4 ALC Bio Innovations Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 ALC Bio Innovations Recent Developments/Updates
7.11.6 ALC Bio Innovations Competitive Strengths & Weaknesses
7.12 ACADIA Pharmaceuticals
7.12.1 ACADIA Pharmaceuticals Details
7.12.2 ACADIA Pharmaceuticals Major Business
7.12.3 ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Product and Services
7.12.4 ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 ACADIA Pharmaceuticals Recent Developments/Updates
7.12.6 ACADIA Pharmaceuticals Competitive Strengths & Weaknesses
7.13 AbbVie
7.13.1 AbbVie Details
7.13.2 AbbVie Major Business
7.13.3 AbbVie Biological Pentylenediamine for Medicine Product and Services
7.13.4 AbbVie Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 AbbVie Recent Developments/Updates
7.13.6 AbbVie Competitive Strengths & Weaknesses
7.14 Ology Bioservices
7.14.1 Ology Bioservices Details
7.14.2 Ology Bioservices Major Business
7.14.3 Ology Bioservices Biological Pentylenediamine for Medicine Product and Services
7.14.4 Ology Bioservices Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Ology Bioservices Recent Developments/Updates
7.14.6 Ology Bioservices Competitive Strengths & Weaknesses
7.15 QMI - Quality Management
7.15.1 QMI - Quality Management Details
7.15.2 QMI - Quality Management Major Business
7.15.3 QMI - Quality Management Biological Pentylenediamine for Medicine Product and Services
7.15.4 QMI - Quality Management Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 QMI - Quality Management Recent Developments/Updates
7.15.6 QMI - Quality Management Competitive Strengths & Weaknesses
7.16 Biomiga
7.16.1 Biomiga Details
7.16.2 Biomiga Major Business
7.16.3 Biomiga Biological Pentylenediamine for Medicine Product and Services
7.16.4 Biomiga Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Biomiga Recent Developments/Updates
7.16.6 Biomiga Competitive Strengths & Weaknesses
7.17 Molecular Targeting Technologies
7.17.1 Molecular Targeting Technologies Details
7.17.2 Molecular Targeting Technologies Major Business
7.17.3 Molecular Targeting Technologies Biological Pentylenediamine for Medicine Product and Services
7.17.4 Molecular Targeting Technologies Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Molecular Targeting Technologies Recent Developments/Updates
7.17.6 Molecular Targeting Technologies Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biological Pentylenediamine for Medicine Industry Chain
8.2 Biological Pentylenediamine for Medicine Upstream Analysis
8.2.1 Biological Pentylenediamine for Medicine Core Raw Materials
8.2.2 Main Manufacturers of Biological Pentylenediamine for Medicine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Biological Pentylenediamine for Medicine Production Mode
8.6 Biological Pentylenediamine for Medicine Procurement Model
8.7 Biological Pentylenediamine for Medicine Industry Sales Model and Sales Channels
8.7.1 Biological Pentylenediamine for Medicine Sales Model
8.7.2 Biological Pentylenediamine for Medicine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Biological Pentylenediamine for Medicine Introduction
1.2 World Biological Pentylenediamine for Medicine Supply & Forecast
1.2.1 World Biological Pentylenediamine for Medicine Production Value (2018 & 2022 & 2029)
1.2.2 World Biological Pentylenediamine for Medicine Production (2018-2029)
1.2.3 World Biological Pentylenediamine for Medicine Pricing Trends (2018-2029)
1.3 World Biological Pentylenediamine for Medicine Production by Region (Based on Production Site)
1.3.1 World Biological Pentylenediamine for Medicine Production Value by Region (2018-2029)
1.3.2 World Biological Pentylenediamine for Medicine Production by Region (2018-2029)
1.3.3 World Biological Pentylenediamine for Medicine Average Price by Region (2018-2029)
1.3.4 North America Biological Pentylenediamine for Medicine Production (2018-2029)
1.3.5 Europe Biological Pentylenediamine for Medicine Production (2018-2029)
1.3.6 China Biological Pentylenediamine for Medicine Production (2018-2029)
1.3.7 Japan Biological Pentylenediamine for Medicine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biological Pentylenediamine for Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biological Pentylenediamine for Medicine Major Market Trends
2 DEMAND SUMMARY
2.1 World Biological Pentylenediamine for Medicine Demand (2018-2029)
2.2 World Biological Pentylenediamine for Medicine Consumption by Region
2.2.1 World Biological Pentylenediamine for Medicine Consumption by Region (2018-2023)
2.2.2 World Biological Pentylenediamine for Medicine Consumption Forecast by Region (2024-2029)
2.3 United States Biological Pentylenediamine for Medicine Consumption (2018-2029)
2.4 China Biological Pentylenediamine for Medicine Consumption (2018-2029)
2.5 Europe Biological Pentylenediamine for Medicine Consumption (2018-2029)
2.6 Japan Biological Pentylenediamine for Medicine Consumption (2018-2029)
2.7 South Korea Biological Pentylenediamine for Medicine Consumption (2018-2029)
2.8 ASEAN Biological Pentylenediamine for Medicine Consumption (2018-2029)
2.9 India Biological Pentylenediamine for Medicine Consumption (2018-2029)
3 WORLD BIOLOGICAL PENTYLENEDIAMINE FOR MEDICINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Biological Pentylenediamine for Medicine Production Value by Manufacturer (2018-2023)
3.2 World Biological Pentylenediamine for Medicine Production by Manufacturer (2018-2023)
3.3 World Biological Pentylenediamine for Medicine Average Price by Manufacturer (2018-2023)
3.4 Biological Pentylenediamine for Medicine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biological Pentylenediamine for Medicine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biological Pentylenediamine for Medicine in 2022
3.5.3 Global Concentration Ratios (CR8) for Biological Pentylenediamine for Medicine in 2022
3.6 Biological Pentylenediamine for Medicine Market: Overall Company Footprint Analysis
3.6.1 Biological Pentylenediamine for Medicine Market: Region Footprint
3.6.2 Biological Pentylenediamine for Medicine Market: Company Product Type Footprint
3.6.3 Biological Pentylenediamine for Medicine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Biological Pentylenediamine for Medicine Production Value Comparison
4.1.1 United States VS China: Biological Pentylenediamine for Medicine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Biological Pentylenediamine for Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Biological Pentylenediamine for Medicine Production Comparison
4.2.1 United States VS China: Biological Pentylenediamine for Medicine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biological Pentylenediamine for Medicine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Biological Pentylenediamine for Medicine Consumption Comparison
4.3.1 United States VS China: Biological Pentylenediamine for Medicine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Biological Pentylenediamine for Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Biological Pentylenediamine for Medicine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Biological Pentylenediamine for Medicine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Biological Pentylenediamine for Medicine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Biological Pentylenediamine for Medicine Production (2018-2023)
4.5 China Based Biological Pentylenediamine for Medicine Manufacturers and Market Share
4.5.1 China Based Biological Pentylenediamine for Medicine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Biological Pentylenediamine for Medicine Production Value (2018-2023)
4.5.3 China Based Manufacturers Biological Pentylenediamine for Medicine Production (2018-2023)
4.6 Rest of World Based Biological Pentylenediamine for Medicine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Biological Pentylenediamine for Medicine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Biological Pentylenediamine for Medicine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Biological Pentylenediamine for Medicine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biological Pentylenediamine for Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Purity 98.5%-99%
5.2.2 Purity ?99%
5.3 Market Segment by Type
5.3.1 World Biological Pentylenediamine for Medicine Production by Type (2018-2029)
5.3.2 World Biological Pentylenediamine for Medicine Production Value by Type (2018-2029)
5.3.3 World Biological Pentylenediamine for Medicine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biological Pentylenediamine for Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Industry
6.2.2 Medical Research
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Biological Pentylenediamine for Medicine Production by Application (2018-2029)
6.3.2 World Biological Pentylenediamine for Medicine Production Value by Application (2018-2029)
6.3.3 World Biological Pentylenediamine for Medicine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Cathay Biotech
7.1.1 Cathay Biotech Details
7.1.2 Cathay Biotech Major Business
7.1.3 Cathay Biotech Biological Pentylenediamine for Medicine Product and Services
7.1.4 Cathay Biotech Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Cathay Biotech Recent Developments/Updates
7.1.6 Cathay Biotech Competitive Strengths & Weaknesses
7.2 Aphena Pharma Solutions
7.2.1 Aphena Pharma Solutions Details
7.2.2 Aphena Pharma Solutions Major Business
7.2.3 Aphena Pharma Solutions Biological Pentylenediamine for Medicine Product and Services
7.2.4 Aphena Pharma Solutions Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Aphena Pharma Solutions Recent Developments/Updates
7.2.6 Aphena Pharma Solutions Competitive Strengths & Weaknesses
7.3 Bio-Tech Pharmacal
7.3.1 Bio-Tech Pharmacal Details
7.3.2 Bio-Tech Pharmacal Major Business
7.3.3 Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Product and Services
7.3.4 Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bio-Tech Pharmacal Recent Developments/Updates
7.3.6 Bio-Tech Pharmacal Competitive Strengths & Weaknesses
7.4 Goodwin Biotechnology
7.4.1 Goodwin Biotechnology Details
7.4.2 Goodwin Biotechnology Major Business
7.4.3 Goodwin Biotechnology Biological Pentylenediamine for Medicine Product and Services
7.4.4 Goodwin Biotechnology Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Goodwin Biotechnology Recent Developments/Updates
7.4.6 Goodwin Biotechnology Competitive Strengths & Weaknesses
7.5 Xenon Pharmaceuticals
7.5.1 Xenon Pharmaceuticals Details
7.5.2 Xenon Pharmaceuticals Major Business
7.5.3 Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Product and Services
7.5.4 Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Xenon Pharmaceuticals Recent Developments/Updates
7.5.6 Xenon Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Nektar Therapeutics
7.6.1 Nektar Therapeutics Details
7.6.2 Nektar Therapeutics Major Business
7.6.3 Nektar Therapeutics Biological Pentylenediamine for Medicine Product and Services
7.6.4 Nektar Therapeutics Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Nektar Therapeutics Recent Developments/Updates
7.6.6 Nektar Therapeutics Competitive Strengths & Weaknesses
7.7 Midas Pharmaceuticals
7.7.1 Midas Pharmaceuticals Details
7.7.2 Midas Pharmaceuticals Major Business
7.7.3 Midas Pharmaceuticals Biological Pentylenediamine for Medicine Product and Services
7.7.4 Midas Pharmaceuticals Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Midas Pharmaceuticals Recent Developments/Updates
7.7.6 Midas Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Kedrion Biopharma
7.8.1 Kedrion Biopharma Details
7.8.2 Kedrion Biopharma Major Business
7.8.3 Kedrion Biopharma Biological Pentylenediamine for Medicine Product and Services
7.8.4 Kedrion Biopharma Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Kedrion Biopharma Recent Developments/Updates
7.8.6 Kedrion Biopharma Competitive Strengths & Weaknesses
7.9 Xcelthera
7.9.1 Xcelthera Details
7.9.2 Xcelthera Major Business
7.9.3 Xcelthera Biological Pentylenediamine for Medicine Product and Services
7.9.4 Xcelthera Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Xcelthera Recent Developments/Updates
7.9.6 Xcelthera Competitive Strengths & Weaknesses
7.10 Anichem
7.10.1 Anichem Details
7.10.2 Anichem Major Business
7.10.3 Anichem Biological Pentylenediamine for Medicine Product and Services
7.10.4 Anichem Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Anichem Recent Developments/Updates
7.10.6 Anichem Competitive Strengths & Weaknesses
7.11 ALC Bio Innovations
7.11.1 ALC Bio Innovations Details
7.11.2 ALC Bio Innovations Major Business
7.11.3 ALC Bio Innovations Biological Pentylenediamine for Medicine Product and Services
7.11.4 ALC Bio Innovations Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 ALC Bio Innovations Recent Developments/Updates
7.11.6 ALC Bio Innovations Competitive Strengths & Weaknesses
7.12 ACADIA Pharmaceuticals
7.12.1 ACADIA Pharmaceuticals Details
7.12.2 ACADIA Pharmaceuticals Major Business
7.12.3 ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Product and Services
7.12.4 ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 ACADIA Pharmaceuticals Recent Developments/Updates
7.12.6 ACADIA Pharmaceuticals Competitive Strengths & Weaknesses
7.13 AbbVie
7.13.1 AbbVie Details
7.13.2 AbbVie Major Business
7.13.3 AbbVie Biological Pentylenediamine for Medicine Product and Services
7.13.4 AbbVie Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 AbbVie Recent Developments/Updates
7.13.6 AbbVie Competitive Strengths & Weaknesses
7.14 Ology Bioservices
7.14.1 Ology Bioservices Details
7.14.2 Ology Bioservices Major Business
7.14.3 Ology Bioservices Biological Pentylenediamine for Medicine Product and Services
7.14.4 Ology Bioservices Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Ology Bioservices Recent Developments/Updates
7.14.6 Ology Bioservices Competitive Strengths & Weaknesses
7.15 QMI - Quality Management
7.15.1 QMI - Quality Management Details
7.15.2 QMI - Quality Management Major Business
7.15.3 QMI - Quality Management Biological Pentylenediamine for Medicine Product and Services
7.15.4 QMI - Quality Management Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 QMI - Quality Management Recent Developments/Updates
7.15.6 QMI - Quality Management Competitive Strengths & Weaknesses
7.16 Biomiga
7.16.1 Biomiga Details
7.16.2 Biomiga Major Business
7.16.3 Biomiga Biological Pentylenediamine for Medicine Product and Services
7.16.4 Biomiga Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Biomiga Recent Developments/Updates
7.16.6 Biomiga Competitive Strengths & Weaknesses
7.17 Molecular Targeting Technologies
7.17.1 Molecular Targeting Technologies Details
7.17.2 Molecular Targeting Technologies Major Business
7.17.3 Molecular Targeting Technologies Biological Pentylenediamine for Medicine Product and Services
7.17.4 Molecular Targeting Technologies Biological Pentylenediamine for Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Molecular Targeting Technologies Recent Developments/Updates
7.17.6 Molecular Targeting Technologies Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biological Pentylenediamine for Medicine Industry Chain
8.2 Biological Pentylenediamine for Medicine Upstream Analysis
8.2.1 Biological Pentylenediamine for Medicine Core Raw Materials
8.2.2 Main Manufacturers of Biological Pentylenediamine for Medicine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Biological Pentylenediamine for Medicine Production Mode
8.6 Biological Pentylenediamine for Medicine Procurement Model
8.7 Biological Pentylenediamine for Medicine Industry Sales Model and Sales Channels
8.7.1 Biological Pentylenediamine for Medicine Sales Model
8.7.2 Biological Pentylenediamine for Medicine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Biological Pentylenediamine for Medicine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Biological Pentylenediamine for Medicine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Biological Pentylenediamine for Medicine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Biological Pentylenediamine for Medicine Production Value Market Share by Region (2018-2023)
Table 5. World Biological Pentylenediamine for Medicine Production Value Market Share by Region (2024-2029)
Table 6. World Biological Pentylenediamine for Medicine Production by Region (2018-2023) & (Tons)
Table 7. World Biological Pentylenediamine for Medicine Production by Region (2024-2029) & (Tons)
Table 8. World Biological Pentylenediamine for Medicine Production Market Share by Region (2018-2023)
Table 9. World Biological Pentylenediamine for Medicine Production Market Share by Region (2024-2029)
Table 10. World Biological Pentylenediamine for Medicine Average Price by Region (2018-2023) & (US$/Ton)
Table 11. World Biological Pentylenediamine for Medicine Average Price by Region (2024-2029) & (US$/Ton)
Table 12. Biological Pentylenediamine for Medicine Major Market Trends
Table 13. World Biological Pentylenediamine for Medicine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World Biological Pentylenediamine for Medicine Consumption by Region (2018-2023) & (Tons)
Table 15. World Biological Pentylenediamine for Medicine Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World Biological Pentylenediamine for Medicine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Biological Pentylenediamine for Medicine Producers in 2022
Table 18. World Biological Pentylenediamine for Medicine Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key Biological Pentylenediamine for Medicine Producers in 2022
Table 20. World Biological Pentylenediamine for Medicine Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 21. Global Biological Pentylenediamine for Medicine Company Evaluation Quadrant
Table 22. World Biological Pentylenediamine for Medicine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Biological Pentylenediamine for Medicine Production Site of Key Manufacturer
Table 24. Biological Pentylenediamine for Medicine Market: Company Product Type Footprint
Table 25. Biological Pentylenediamine for Medicine Market: Company Product Application Footprint
Table 26. Biological Pentylenediamine for Medicine Competitive Factors
Table 27. Biological Pentylenediamine for Medicine New Entrant and Capacity Expansion Plans
Table 28. Biological Pentylenediamine for Medicine Mergers & Acquisitions Activity
Table 29. United States VS China Biological Pentylenediamine for Medicine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Biological Pentylenediamine for Medicine Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China Biological Pentylenediamine for Medicine Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based Biological Pentylenediamine for Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Biological Pentylenediamine for Medicine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Biological Pentylenediamine for Medicine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Biological Pentylenediamine for Medicine Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers Biological Pentylenediamine for Medicine Production Market Share (2018-2023)
Table 37. China Based Biological Pentylenediamine for Medicine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Biological Pentylenediamine for Medicine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Biological Pentylenediamine for Medicine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Biological Pentylenediamine for Medicine Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers Biological Pentylenediamine for Medicine Production Market Share (2018-2023)
Table 42. Rest of World Based Biological Pentylenediamine for Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Biological Pentylenediamine for Medicine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Biological Pentylenediamine for Medicine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Biological Pentylenediamine for Medicine Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers Biological Pentylenediamine for Medicine Production Market Share (2018-2023)
Table 47. World Biological Pentylenediamine for Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Biological Pentylenediamine for Medicine Production by Type (2018-2023) & (Tons)
Table 49. World Biological Pentylenediamine for Medicine Production by Type (2024-2029) & (Tons)
Table 50. World Biological Pentylenediamine for Medicine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Biological Pentylenediamine for Medicine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Biological Pentylenediamine for Medicine Average Price by Type (2018-2023) & (US$/Ton)
Table 53. World Biological Pentylenediamine for Medicine Average Price by Type (2024-2029) & (US$/Ton)
Table 54. World Biological Pentylenediamine for Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Biological Pentylenediamine for Medicine Production by Application (2018-2023) & (Tons)
Table 56. World Biological Pentylenediamine for Medicine Production by Application (2024-2029) & (Tons)
Table 57. World Biological Pentylenediamine for Medicine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Biological Pentylenediamine for Medicine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Biological Pentylenediamine for Medicine Average Price by Application (2018-2023) & (US$/Ton)
Table 60. World Biological Pentylenediamine for Medicine Average Price by Application (2024-2029) & (US$/Ton)
Table 61. Cathay Biotech Basic Information, Manufacturing Base and Competitors
Table 62. Cathay Biotech Major Business
Table 63. Cathay Biotech Biological Pentylenediamine for Medicine Product and Services
Table 64. Cathay Biotech Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Cathay Biotech Recent Developments/Updates
Table 66. Cathay Biotech Competitive Strengths & Weaknesses
Table 67. Aphena Pharma Solutions Basic Information, Manufacturing Base and Competitors
Table 68. Aphena Pharma Solutions Major Business
Table 69. Aphena Pharma Solutions Biological Pentylenediamine for Medicine Product and Services
Table 70. Aphena Pharma Solutions Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Aphena Pharma Solutions Recent Developments/Updates
Table 72. Aphena Pharma Solutions Competitive Strengths & Weaknesses
Table 73. Bio-Tech Pharmacal Basic Information, Manufacturing Base and Competitors
Table 74. Bio-Tech Pharmacal Major Business
Table 75. Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Product and Services
Table 76. Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bio-Tech Pharmacal Recent Developments/Updates
Table 78. Bio-Tech Pharmacal Competitive Strengths & Weaknesses
Table 79. Goodwin Biotechnology Basic Information, Manufacturing Base and Competitors
Table 80. Goodwin Biotechnology Major Business
Table 81. Goodwin Biotechnology Biological Pentylenediamine for Medicine Product and Services
Table 82. Goodwin Biotechnology Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Goodwin Biotechnology Recent Developments/Updates
Table 84. Goodwin Biotechnology Competitive Strengths & Weaknesses
Table 85. Xenon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Xenon Pharmaceuticals Major Business
Table 87. Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Product and Services
Table 88. Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Xenon Pharmaceuticals Recent Developments/Updates
Table 90. Xenon Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table 92. Nektar Therapeutics Major Business
Table 93. Nektar Therapeutics Biological Pentylenediamine for Medicine Product and Services
Table 94. Nektar Therapeutics Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Nektar Therapeutics Recent Developments/Updates
Table 96. Nektar Therapeutics Competitive Strengths & Weaknesses
Table 97. Midas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. Midas Pharmaceuticals Major Business
Table 99. Midas Pharmaceuticals Biological Pentylenediamine for Medicine Product and Services
Table 100. Midas Pharmaceuticals Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Midas Pharmaceuticals Recent Developments/Updates
Table 102. Midas Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 104. Kedrion Biopharma Major Business
Table 105. Kedrion Biopharma Biological Pentylenediamine for Medicine Product and Services
Table 106. Kedrion Biopharma Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Kedrion Biopharma Recent Developments/Updates
Table 108. Kedrion Biopharma Competitive Strengths & Weaknesses
Table 109. Xcelthera Basic Information, Manufacturing Base and Competitors
Table 110. Xcelthera Major Business
Table 111. Xcelthera Biological Pentylenediamine for Medicine Product and Services
Table 112. Xcelthera Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Xcelthera Recent Developments/Updates
Table 114. Xcelthera Competitive Strengths & Weaknesses
Table 115. Anichem Basic Information, Manufacturing Base and Competitors
Table 116. Anichem Major Business
Table 117. Anichem Biological Pentylenediamine for Medicine Product and Services
Table 118. Anichem Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Anichem Recent Developments/Updates
Table 120. Anichem Competitive Strengths & Weaknesses
Table 121. ALC Bio Innovations Basic Information, Manufacturing Base and Competitors
Table 122. ALC Bio Innovations Major Business
Table 123. ALC Bio Innovations Biological Pentylenediamine for Medicine Product and Services
Table 124. ALC Bio Innovations Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. ALC Bio Innovations Recent Developments/Updates
Table 126. ALC Bio Innovations Competitive Strengths & Weaknesses
Table 127. ACADIA Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 128. ACADIA Pharmaceuticals Major Business
Table 129. ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Product and Services
Table 130. ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. ACADIA Pharmaceuticals Recent Developments/Updates
Table 132. ACADIA Pharmaceuticals Competitive Strengths & Weaknesses
Table 133. AbbVie Basic Information, Manufacturing Base and Competitors
Table 134. AbbVie Major Business
Table 135. AbbVie Biological Pentylenediamine for Medicine Product and Services
Table 136. AbbVie Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. AbbVie Recent Developments/Updates
Table 138. AbbVie Competitive Strengths & Weaknesses
Table 139. Ology Bioservices Basic Information, Manufacturing Base and Competitors
Table 140. Ology Bioservices Major Business
Table 141. Ology Bioservices Biological Pentylenediamine for Medicine Product and Services
Table 142. Ology Bioservices Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Ology Bioservices Recent Developments/Updates
Table 144. Ology Bioservices Competitive Strengths & Weaknesses
Table 145. QMI - Quality Management Basic Information, Manufacturing Base and Competitors
Table 146. QMI - Quality Management Major Business
Table 147. QMI - Quality Management Biological Pentylenediamine for Medicine Product and Services
Table 148. QMI - Quality Management Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. QMI - Quality Management Recent Developments/Updates
Table 150. QMI - Quality Management Competitive Strengths & Weaknesses
Table 151. Biomiga Basic Information, Manufacturing Base and Competitors
Table 152. Biomiga Major Business
Table 153. Biomiga Biological Pentylenediamine for Medicine Product and Services
Table 154. Biomiga Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Biomiga Recent Developments/Updates
Table 156. Molecular Targeting Technologies Basic Information, Manufacturing Base and Competitors
Table 157. Molecular Targeting Technologies Major Business
Table 158. Molecular Targeting Technologies Biological Pentylenediamine for Medicine Product and Services
Table 159. Molecular Targeting Technologies Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of Biological Pentylenediamine for Medicine Upstream (Raw Materials)
Table 161. Biological Pentylenediamine for Medicine Typical Customers
Table 162. Biological Pentylenediamine for Medicine Typical Distributors
List of Figure
Figure 1. Biological Pentylenediamine for Medicine Picture
Figure 2. World Biological Pentylenediamine for Medicine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biological Pentylenediamine for Medicine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Biological Pentylenediamine for Medicine Production (2018-2029) & (Tons)
Figure 5. World Biological Pentylenediamine for Medicine Average Price (2018-2029) & (US$/Ton)
Figure 6. World Biological Pentylenediamine for Medicine Production Value Market Share by Region (2018-2029)
Figure 7. World Biological Pentylenediamine for Medicine Production Market Share by Region (2018-2029)
Figure 8. North America Biological Pentylenediamine for Medicine Production (2018-2029) & (Tons)
Figure 9. Europe Biological Pentylenediamine for Medicine Production (2018-2029) & (Tons)
Figure 10. China Biological Pentylenediamine for Medicine Production (2018-2029) & (Tons)
Figure 11. Japan Biological Pentylenediamine for Medicine Production (2018-2029) & (Tons)
Figure 12. Biological Pentylenediamine for Medicine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 15. World Biological Pentylenediamine for Medicine Consumption Market Share by Region (2018-2029)
Figure 16. United States Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 17. China Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 18. Europe Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 19. Japan Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 20. South Korea Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 21. ASEAN Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 22. India Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of Biological Pentylenediamine for Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Biological Pentylenediamine for Medicine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Biological Pentylenediamine for Medicine Markets in 2022
Figure 26. United States VS China: Biological Pentylenediamine for Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Biological Pentylenediamine for Medicine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biological Pentylenediamine for Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Biological Pentylenediamine for Medicine Production Market Share 2022
Figure 30. China Based Manufacturers Biological Pentylenediamine for Medicine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Biological Pentylenediamine for Medicine Production Market Share 2022
Figure 32. World Biological Pentylenediamine for Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Biological Pentylenediamine for Medicine Production Value Market Share by Type in 2022
Figure 34. Purity 98.5%-99%
Figure 35. Purity ?99%
Figure 36. World Biological Pentylenediamine for Medicine Production Market Share by Type (2018-2029)
Figure 37. World Biological Pentylenediamine for Medicine Production Value Market Share by Type (2018-2029)
Figure 38. World Biological Pentylenediamine for Medicine Average Price by Type (2018-2029) & (US$/Ton)
Figure 39. World Biological Pentylenediamine for Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Biological Pentylenediamine for Medicine Production Value Market Share by Application in 2022
Figure 41. Pharmaceutical Industry
Figure 42. Medical Research
Figure 43. Others
Figure 44. World Biological Pentylenediamine for Medicine Production Market Share by Application (2018-2029)
Figure 45. World Biological Pentylenediamine for Medicine Production Value Market Share by Application (2018-2029)
Figure 46. World Biological Pentylenediamine for Medicine Average Price by Application (2018-2029) & (US$/Ton)
Figure 47. Biological Pentylenediamine for Medicine Industry Chain
Figure 48. Biological Pentylenediamine for Medicine Procurement Model
Figure 49. Biological Pentylenediamine for Medicine Sales Model
Figure 50. Biological Pentylenediamine for Medicine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Table 1. World Biological Pentylenediamine for Medicine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Biological Pentylenediamine for Medicine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Biological Pentylenediamine for Medicine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Biological Pentylenediamine for Medicine Production Value Market Share by Region (2018-2023)
Table 5. World Biological Pentylenediamine for Medicine Production Value Market Share by Region (2024-2029)
Table 6. World Biological Pentylenediamine for Medicine Production by Region (2018-2023) & (Tons)
Table 7. World Biological Pentylenediamine for Medicine Production by Region (2024-2029) & (Tons)
Table 8. World Biological Pentylenediamine for Medicine Production Market Share by Region (2018-2023)
Table 9. World Biological Pentylenediamine for Medicine Production Market Share by Region (2024-2029)
Table 10. World Biological Pentylenediamine for Medicine Average Price by Region (2018-2023) & (US$/Ton)
Table 11. World Biological Pentylenediamine for Medicine Average Price by Region (2024-2029) & (US$/Ton)
Table 12. Biological Pentylenediamine for Medicine Major Market Trends
Table 13. World Biological Pentylenediamine for Medicine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World Biological Pentylenediamine for Medicine Consumption by Region (2018-2023) & (Tons)
Table 15. World Biological Pentylenediamine for Medicine Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World Biological Pentylenediamine for Medicine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Biological Pentylenediamine for Medicine Producers in 2022
Table 18. World Biological Pentylenediamine for Medicine Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key Biological Pentylenediamine for Medicine Producers in 2022
Table 20. World Biological Pentylenediamine for Medicine Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 21. Global Biological Pentylenediamine for Medicine Company Evaluation Quadrant
Table 22. World Biological Pentylenediamine for Medicine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Biological Pentylenediamine for Medicine Production Site of Key Manufacturer
Table 24. Biological Pentylenediamine for Medicine Market: Company Product Type Footprint
Table 25. Biological Pentylenediamine for Medicine Market: Company Product Application Footprint
Table 26. Biological Pentylenediamine for Medicine Competitive Factors
Table 27. Biological Pentylenediamine for Medicine New Entrant and Capacity Expansion Plans
Table 28. Biological Pentylenediamine for Medicine Mergers & Acquisitions Activity
Table 29. United States VS China Biological Pentylenediamine for Medicine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Biological Pentylenediamine for Medicine Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China Biological Pentylenediamine for Medicine Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based Biological Pentylenediamine for Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Biological Pentylenediamine for Medicine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Biological Pentylenediamine for Medicine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Biological Pentylenediamine for Medicine Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers Biological Pentylenediamine for Medicine Production Market Share (2018-2023)
Table 37. China Based Biological Pentylenediamine for Medicine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Biological Pentylenediamine for Medicine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Biological Pentylenediamine for Medicine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Biological Pentylenediamine for Medicine Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers Biological Pentylenediamine for Medicine Production Market Share (2018-2023)
Table 42. Rest of World Based Biological Pentylenediamine for Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Biological Pentylenediamine for Medicine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Biological Pentylenediamine for Medicine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Biological Pentylenediamine for Medicine Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers Biological Pentylenediamine for Medicine Production Market Share (2018-2023)
Table 47. World Biological Pentylenediamine for Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Biological Pentylenediamine for Medicine Production by Type (2018-2023) & (Tons)
Table 49. World Biological Pentylenediamine for Medicine Production by Type (2024-2029) & (Tons)
Table 50. World Biological Pentylenediamine for Medicine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Biological Pentylenediamine for Medicine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Biological Pentylenediamine for Medicine Average Price by Type (2018-2023) & (US$/Ton)
Table 53. World Biological Pentylenediamine for Medicine Average Price by Type (2024-2029) & (US$/Ton)
Table 54. World Biological Pentylenediamine for Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Biological Pentylenediamine for Medicine Production by Application (2018-2023) & (Tons)
Table 56. World Biological Pentylenediamine for Medicine Production by Application (2024-2029) & (Tons)
Table 57. World Biological Pentylenediamine for Medicine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Biological Pentylenediamine for Medicine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Biological Pentylenediamine for Medicine Average Price by Application (2018-2023) & (US$/Ton)
Table 60. World Biological Pentylenediamine for Medicine Average Price by Application (2024-2029) & (US$/Ton)
Table 61. Cathay Biotech Basic Information, Manufacturing Base and Competitors
Table 62. Cathay Biotech Major Business
Table 63. Cathay Biotech Biological Pentylenediamine for Medicine Product and Services
Table 64. Cathay Biotech Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Cathay Biotech Recent Developments/Updates
Table 66. Cathay Biotech Competitive Strengths & Weaknesses
Table 67. Aphena Pharma Solutions Basic Information, Manufacturing Base and Competitors
Table 68. Aphena Pharma Solutions Major Business
Table 69. Aphena Pharma Solutions Biological Pentylenediamine for Medicine Product and Services
Table 70. Aphena Pharma Solutions Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Aphena Pharma Solutions Recent Developments/Updates
Table 72. Aphena Pharma Solutions Competitive Strengths & Weaknesses
Table 73. Bio-Tech Pharmacal Basic Information, Manufacturing Base and Competitors
Table 74. Bio-Tech Pharmacal Major Business
Table 75. Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Product and Services
Table 76. Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bio-Tech Pharmacal Recent Developments/Updates
Table 78. Bio-Tech Pharmacal Competitive Strengths & Weaknesses
Table 79. Goodwin Biotechnology Basic Information, Manufacturing Base and Competitors
Table 80. Goodwin Biotechnology Major Business
Table 81. Goodwin Biotechnology Biological Pentylenediamine for Medicine Product and Services
Table 82. Goodwin Biotechnology Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Goodwin Biotechnology Recent Developments/Updates
Table 84. Goodwin Biotechnology Competitive Strengths & Weaknesses
Table 85. Xenon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Xenon Pharmaceuticals Major Business
Table 87. Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Product and Services
Table 88. Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Xenon Pharmaceuticals Recent Developments/Updates
Table 90. Xenon Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table 92. Nektar Therapeutics Major Business
Table 93. Nektar Therapeutics Biological Pentylenediamine for Medicine Product and Services
Table 94. Nektar Therapeutics Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Nektar Therapeutics Recent Developments/Updates
Table 96. Nektar Therapeutics Competitive Strengths & Weaknesses
Table 97. Midas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. Midas Pharmaceuticals Major Business
Table 99. Midas Pharmaceuticals Biological Pentylenediamine for Medicine Product and Services
Table 100. Midas Pharmaceuticals Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Midas Pharmaceuticals Recent Developments/Updates
Table 102. Midas Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 104. Kedrion Biopharma Major Business
Table 105. Kedrion Biopharma Biological Pentylenediamine for Medicine Product and Services
Table 106. Kedrion Biopharma Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Kedrion Biopharma Recent Developments/Updates
Table 108. Kedrion Biopharma Competitive Strengths & Weaknesses
Table 109. Xcelthera Basic Information, Manufacturing Base and Competitors
Table 110. Xcelthera Major Business
Table 111. Xcelthera Biological Pentylenediamine for Medicine Product and Services
Table 112. Xcelthera Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Xcelthera Recent Developments/Updates
Table 114. Xcelthera Competitive Strengths & Weaknesses
Table 115. Anichem Basic Information, Manufacturing Base and Competitors
Table 116. Anichem Major Business
Table 117. Anichem Biological Pentylenediamine for Medicine Product and Services
Table 118. Anichem Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Anichem Recent Developments/Updates
Table 120. Anichem Competitive Strengths & Weaknesses
Table 121. ALC Bio Innovations Basic Information, Manufacturing Base and Competitors
Table 122. ALC Bio Innovations Major Business
Table 123. ALC Bio Innovations Biological Pentylenediamine for Medicine Product and Services
Table 124. ALC Bio Innovations Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. ALC Bio Innovations Recent Developments/Updates
Table 126. ALC Bio Innovations Competitive Strengths & Weaknesses
Table 127. ACADIA Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 128. ACADIA Pharmaceuticals Major Business
Table 129. ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Product and Services
Table 130. ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. ACADIA Pharmaceuticals Recent Developments/Updates
Table 132. ACADIA Pharmaceuticals Competitive Strengths & Weaknesses
Table 133. AbbVie Basic Information, Manufacturing Base and Competitors
Table 134. AbbVie Major Business
Table 135. AbbVie Biological Pentylenediamine for Medicine Product and Services
Table 136. AbbVie Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. AbbVie Recent Developments/Updates
Table 138. AbbVie Competitive Strengths & Weaknesses
Table 139. Ology Bioservices Basic Information, Manufacturing Base and Competitors
Table 140. Ology Bioservices Major Business
Table 141. Ology Bioservices Biological Pentylenediamine for Medicine Product and Services
Table 142. Ology Bioservices Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Ology Bioservices Recent Developments/Updates
Table 144. Ology Bioservices Competitive Strengths & Weaknesses
Table 145. QMI - Quality Management Basic Information, Manufacturing Base and Competitors
Table 146. QMI - Quality Management Major Business
Table 147. QMI - Quality Management Biological Pentylenediamine for Medicine Product and Services
Table 148. QMI - Quality Management Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. QMI - Quality Management Recent Developments/Updates
Table 150. QMI - Quality Management Competitive Strengths & Weaknesses
Table 151. Biomiga Basic Information, Manufacturing Base and Competitors
Table 152. Biomiga Major Business
Table 153. Biomiga Biological Pentylenediamine for Medicine Product and Services
Table 154. Biomiga Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Biomiga Recent Developments/Updates
Table 156. Molecular Targeting Technologies Basic Information, Manufacturing Base and Competitors
Table 157. Molecular Targeting Technologies Major Business
Table 158. Molecular Targeting Technologies Biological Pentylenediamine for Medicine Product and Services
Table 159. Molecular Targeting Technologies Biological Pentylenediamine for Medicine Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of Biological Pentylenediamine for Medicine Upstream (Raw Materials)
Table 161. Biological Pentylenediamine for Medicine Typical Customers
Table 162. Biological Pentylenediamine for Medicine Typical Distributors
List of Figure
Figure 1. Biological Pentylenediamine for Medicine Picture
Figure 2. World Biological Pentylenediamine for Medicine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biological Pentylenediamine for Medicine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Biological Pentylenediamine for Medicine Production (2018-2029) & (Tons)
Figure 5. World Biological Pentylenediamine for Medicine Average Price (2018-2029) & (US$/Ton)
Figure 6. World Biological Pentylenediamine for Medicine Production Value Market Share by Region (2018-2029)
Figure 7. World Biological Pentylenediamine for Medicine Production Market Share by Region (2018-2029)
Figure 8. North America Biological Pentylenediamine for Medicine Production (2018-2029) & (Tons)
Figure 9. Europe Biological Pentylenediamine for Medicine Production (2018-2029) & (Tons)
Figure 10. China Biological Pentylenediamine for Medicine Production (2018-2029) & (Tons)
Figure 11. Japan Biological Pentylenediamine for Medicine Production (2018-2029) & (Tons)
Figure 12. Biological Pentylenediamine for Medicine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 15. World Biological Pentylenediamine for Medicine Consumption Market Share by Region (2018-2029)
Figure 16. United States Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 17. China Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 18. Europe Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 19. Japan Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 20. South Korea Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 21. ASEAN Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 22. India Biological Pentylenediamine for Medicine Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of Biological Pentylenediamine for Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Biological Pentylenediamine for Medicine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Biological Pentylenediamine for Medicine Markets in 2022
Figure 26. United States VS China: Biological Pentylenediamine for Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Biological Pentylenediamine for Medicine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biological Pentylenediamine for Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Biological Pentylenediamine for Medicine Production Market Share 2022
Figure 30. China Based Manufacturers Biological Pentylenediamine for Medicine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Biological Pentylenediamine for Medicine Production Market Share 2022
Figure 32. World Biological Pentylenediamine for Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Biological Pentylenediamine for Medicine Production Value Market Share by Type in 2022
Figure 34. Purity 98.5%-99%
Figure 35. Purity ?99%
Figure 36. World Biological Pentylenediamine for Medicine Production Market Share by Type (2018-2029)
Figure 37. World Biological Pentylenediamine for Medicine Production Value Market Share by Type (2018-2029)
Figure 38. World Biological Pentylenediamine for Medicine Average Price by Type (2018-2029) & (US$/Ton)
Figure 39. World Biological Pentylenediamine for Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Biological Pentylenediamine for Medicine Production Value Market Share by Application in 2022
Figure 41. Pharmaceutical Industry
Figure 42. Medical Research
Figure 43. Others
Figure 44. World Biological Pentylenediamine for Medicine Production Market Share by Application (2018-2029)
Figure 45. World Biological Pentylenediamine for Medicine Production Value Market Share by Application (2018-2029)
Figure 46. World Biological Pentylenediamine for Medicine Average Price by Application (2018-2029) & (US$/Ton)
Figure 47. Biological Pentylenediamine for Medicine Industry Chain
Figure 48. Biological Pentylenediamine for Medicine Procurement Model
Figure 49. Biological Pentylenediamine for Medicine Sales Model
Figure 50. Biological Pentylenediamine for Medicine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
